Non-invasive Prediction of EArly Cardiac rEjection
for Heart Transplant
Sites in Milwaukee +21 more locations
Sponsor: Vanderbilt University Medical Center
Sex: All·Age: 6 - 25
Code: NCT07770659·Recruiting·Listed Aug 18, 2026
Clinical Trials at Medical College of Wisconsin
As of September 2026, 229 paid clinical trials are recruiting at Medical College of Wisconsin, located at Medical College of Wisconsin: Todd Wehr Library, 8701 W Watertown Plank Rd, Milwaukee, WI 53226, phone (414) 456-8300 in Milwaukee, Wisconsin. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Breast Cancer and Heart Failure. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Milwaukee
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
230 clinical trials at Medical College of Wisconsin
·Clear filters· Get a weekly email when new trials open in Milwaukee, WI.
A Study of Buntanetap in Participants With PD
for Parkinson's Disease (PD)
Sites in Milwaukee +26 more locations
Sponsor: Annovis Bio Inc.
Sex: All·Age: 40 - 85
Code: NCT07284784·Phase 2, Phase 3·Recruiting·Listed Dec 2025
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for Early Breast Cancer
Drug: Ribociclib
Sites in Milwaukee +73 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT05827081·Phase 3·Recruiting·Listed Apr 2023
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Milwaukee +38 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07258511·Phase 3·Recruiting·Listed Dec 2025
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Milwaukee, Madison +89 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06890598·Phase 3·Recruiting·Listed Mar 2025
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for Breast Neoplasms
Drug: Pumitamig
Sites in Milwaukee +70 more locations
Sponsor: BioNTech SE
Sex: All·Age: 18+
Code: NCT07173751·Phase 3·Recruiting·Listed Sep 2025
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Sites in Milwaukee +52 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06136650·Phase 3·Recruiting·Listed Nov 2023
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for Colorectal Neoplasms
Drug: Amivantamab
Sites in Milwaukee +67 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06750094·Phase 3·Recruiting·Listed Dec 2024
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for Lymphoma, Large B-Cell, Diffuse
Drug: Polatuzumab Vedotin
Sites in Milwaukee, Madison +69 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06890884·Phase 2·Recruiting·Listed Mar 2025
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for NonSegmental Vitiligo
Drug: Ruxolitinib
Sites in Milwaukee, Madison +67 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 2 - 11
Code: NCT06548360·Phase 3·Recruiting·Listed Aug 2024
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
for Prostate Cancer Metastatic
Sites in Milwaukee +32 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06136624·Phase 3·Recruiting·Listed Nov 2023
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
for Tricuspid Regurgitation
Sites in Milwaukee +44 more locations
Sponsor: Edwards Lifesciences
Sex: All·Age: 18+
Code: NCT04097145·Recruiting·Listed Sep 2019
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for Prostate Cancer
Sites in Milwaukee +34 more locations
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06780670·Phase 2, Phase 3·Recruiting·Listed Jan 2025
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
for Parkinson Disease
Sites in Milwaukee +44 more locations
Sponsor: Neuron23 Inc.
Sex: All·Age: 40 - 80
Code: NCT06680830·Phase 2·Recruiting·Listed Nov 2024
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for Prostate Cancer
Sites in Milwaukee, Madison +48 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: Male·Age: 18+
Code: NCT06925737·Phase 3·Recruiting·Listed Apr 2025
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for Prostate Cancer
Sites in Milwaukee +37 more locations
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT06855277·Phase 3·Recruiting·Listed Mar 2025
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
for Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Drug: Avacopan
Sites in Milwaukee +57 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 100
Code: NCT06072482·Phase 4·Recruiting·Listed Oct 2023
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for cGVHD
Sites in Milwaukee +30 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT05919511·Recruiting·Listed Jun 2023
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
for Relapsed Non-Hodgkin Lymphoma
Sites in Milwaukee +31 more locations
Sponsor: Lyell Immunopharma, Inc.
Sex: All·Age: 18+
Code: NCT05826535·Phase 1, Phase 2·Recruiting·Listed Apr 2023
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for Relapsing Multiple Sclerosis
Drug: Remibrutinib
Sites in Milwaukee, Greenfield +41 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 40 - 70
Code: NCT06846281·Phase 3·Recruiting·Listed Feb 2025
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Sites in Milwaukee, Madison +68 more locations
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT06388421·Recruiting·Listed Apr 2024
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
for Neoplasms
Sites in Milwaukee +24 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 1 - 39
Code: NCT05999994·Phase 2·Recruiting·Listed Aug 2023
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for Small Cell Lung Cancer
Sites in Milwaukee +29 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06203210·Phase 3·Recruiting·Listed Jan 2024
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
for Progressive Pulmonary Fibrosis
Sites in Milwaukee, Madison +72 more locations
Sponsor: United Therapeutics
Sex: All·Age: 18+
Code: NCT05943535·Phase 3·Recruiting·Listed Jul 2023
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
for Pulmonary Embolism
Sites in Milwaukee +54 more locations
Sponsor: Penumbra Inc.
Sex: All·Age: 18+
Code: NCT04798261·Recruiting·Listed Mar 2021
Tracking Results of Ablations to Combat AF Registry Generation 2
for Atrial Fibrillation
Sites in Milwaukee +25 more locations
Sponsor: AtriCure, Inc.
Sex: All·Age: 18+
Code: NCT05111015·Recruiting·Listed Nov 2021
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for Mesial Temporal Lobe Epilepsy
Sites in Milwaukee +34 more locations
Sponsor: Neurona Therapeutics
Sex: All·Age: 18 - 75
Code: NCT05135091·Phase 3·Recruiting·Listed Nov 2021
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for Graft-versus-host Disease (GVHD)
Drug: Ruxolitinib
Sites in Milwaukee, Madison +28 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT06615050·Phase 3·Recruiting·Listed Sep 2024
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
for Gastrointestinal Stromal Tumor (GIST)
Sites in Milwaukee +31 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06655246·Phase 1·Recruiting·Listed Oct 2024
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
for AAA - Abdominal Aortic Aneurysm
Sites in Milwaukee +55 more locations
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT06218875·Recruiting·Listed Jan 2024
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for Extensive Stage-small Cell Lung Cancer
Drug: Atezolizumab
Sites in Milwaukee +24 more locations
Sponsor: Daiichi Sankyo
Sex: All·Age: 18+
Code: NCT06362252·Phase 1, Phase 2·Recruiting·Listed Apr 2024
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
for Traumatic Brain Injury
Sites in Milwaukee +12 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT07455136·Recruiting·Listed Mar 2026
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
for Myeloproliferative Neoplasms
Drug: INCA036978
Sites in Milwaukee +22 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT07441694·Phase 1·Recruiting·Listed Mar 2026
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
for Plaque Psoriasis
Drug: Zasocitinib
Sites in Milwaukee +10 more locations
Sponsor: Takeda
Sex: All·Age: 4 - 17
Code: NCT07250802·Phase 3·Recruiting·Listed Nov 2025
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation
for Microvascular Inflammation
Sites in Milwaukee +22 more locations
Sponsor: Biogen
Sex: All·Age: 18 - 74
Code: NCT07219043·Phase 2·Recruiting·Listed Oct 2025
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
for Aortic Arch Dissection
Sites in Milwaukee, Madison +16 more locations
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT07166133·Recruiting·Listed Sep 2025
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for Metastatic Solid Tumor
Sites in Milwaukee +15 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06561685·Phase 1·Recruiting·Listed Aug 2024
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
for Esophageal Cancer
Sites in Milwaukee +15 more locations
Sponsor: SOFIE
Sex: All·Age: 18+
Code: NCT07217704·Phase 3·Recruiting·Listed Oct 2025
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
for Pancreatic Ductal Adenocarcinoma (PDAC)
Sites in Milwaukee +15 more locations
Sponsor: SOFIE
Sex: All·Age: 18+
Code: NCT07217717·Phase 3·Recruiting·Listed Oct 2025
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
for Relapsed or Refractory Multiple Myeloma (RRMM)
Sites in Milwaukee +16 more locations
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All·Age: 18+
Code: NCT06615479·Phase 3·Recruiting·Listed Sep 2024
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
for Mesial Temporal Lobe Epilepsy
Sites in Milwaukee +15 more locations
Sponsor: UniQure Biopharma B.V.
Sex: All·Age: 18 - 75
Code: NCT06063850·Phase 1, Phase 2·Recruiting·Listed Oct 2023
Common conditions studied in Milwaukee
- Acute Myeloid Leukemia (15 active studies)
- Breast Cancer (15 active studies)
- Heart Failure (13 active studies)
- Chronic Lymphocytic Leukemia (10 active studies)
- Follicular Lymphoma (10 active studies)
- Prostate Cancer (10 active studies)
Leading research sponsors in Milwaukee
- Medical College of Wisconsin
- National Cancer Institute (NCI)
- AstraZeneca
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Milwaukee?
There are approximately 675 recruiting clinical trials in Milwaukee, Wisconsin listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Milwaukee pay participants?
Most recruiting trials in Milwaukee compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Milwaukee?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Milwaukee?
The most common conditions under active study in Milwaukee include Acute Myeloid Leukemia (15), Breast Cancer (15), Heart Failure (13), Chronic Lymphocytic Leukemia (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Milwaukee?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Milwaukee on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Milwaukee?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Milwaukee?
Recruiting research sites in Milwaukee include Medical College of Wisconsin, Aurora Sinai Medical Center, Aurora Saint Luke's Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Milwaukee right now?
The largest active categories in Milwaukee are Cancer & tumors (267), Cardiovascular (49), Neurology & pain (36). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Medical College of Wisconsin?
Medical College of Wisconsin is located at Medical College of Wisconsin: Todd Wehr Library, 8701 W Watertown Plank Rd, Milwaukee, WI 53226. Use the Google Maps link in the intro above to get directions.
How do I contact Medical College of Wisconsin?
You can reach Medical College of Wisconsin by phone at (414) 456-8300. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in Wisconsin
Madison, WI(558)Green Bay, WI(112)Marshfield, WI(99)La Crosse, WI(93)Stevens Point, WI(85)Eau Claire, WI(84)Weston, WI(74)Sheboygan, WI(73)Ashland, WI(65)Wauwatosa, WI(63)Kenosha, WI(62)Appleton, WI(61)Oshkosh, WI(57)Wausau, WI(57)Rice Lake, WI(56)Minocqua, WI(55)Sturgeon Bay, WI(55)Racine, WI(51)Grafton, WI(49)New Richmond, WI(49)Summit, WI(48)West Allis, WI(48)Burlington, WI(47)Germantown, WI(47)Marinette, WI(47)Two Rivers, WI(46)Waukesha, WI(46)Oconto Falls, WI(45)Wisconsin Rapids, WI(43)Antigo, WI(39)Cudahy, WI(39)Menomonee Falls, WI(37)Oconomowoc, WI(37)West Bend, WI(37)Mukwonago, WI(35)Oak Creek, WI(35)Rhinelander, WI(35)Spooner, WI(29)Superior, WI(29)Medford, WI(27)Hayward, WI(25)Janesville, WI(20)Neenah, WI(20)Mequon, WI(19)New Berlin, WI(19)Brookfield, WI(16)Franklin, WI(16)Chippewa Falls, WI(15)Johnson Creek, WI(15)Chilton, WI(14)Greenfield, WI(14)Shawano, WI(13)Waupaca, WI(13)Ladysmith, WI(11)Berlin, WI(10)New London, WI(10)Fond du Lac, WI(9)Neillsville, WI(6)Glendale, WI(2)Hudson, WI(2)